251 - 260 of 8459 Results
Title
Year
-
OPENTitle: Lewy body diseases and the gutJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00804-5Citation Count: 0
-
OPENTitle: Adeno-associated viral vectors for modeling Parkinson’s disease in non-human primatesJournal Name: Neural Regeneration ResearchPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/nrr.nrr-d-24-00896Best OA location URL: https://doi.org/10.4103/nrr.nrr-d-24-00896Citation Count: 1
- Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment2025OPENTitle: Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-025-56293-zBest OA location URL: https://doi.org/10.1038/s41467-025-56293-zCitation Count: 0
- Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain2025OPENTitle: Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brainJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 122Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1073/pnas.2412029122Best OA location URL: https://pnas.org/doi/pdf/10.1073/pnas.2412029122Citation Count: 0
- Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition2025OPENTitle: Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid depositionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14351Best OA location URL: https://doi.org/10.1002/alz.14351Citation Count: 0
-
OPENTitle: Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf032Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf032/61635558/awaf032.pdfCitation Count: 0
-
OPENTitle: Splicing accuracy varies across human introns, tissues, age and diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-55607-xBest OA location URL: https://doi.org/10.1038/s41467-024-55607-xCitation Count: 0
- Transcriptomics profiling of Parkinson’s disease progression subtypes reveals distinctive patterns of gene expression2025OPENTitle: Transcriptomics profiling of Parkinson’s disease progression subtypes reveals distinctive patterns of gene expressionJournal Name: Journal of Central Nervous System DiseasePublisher: SAGE PublicationsVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/11795735241286821Best OA location URL: https://doi.org/10.1177/11795735241286821Citation Count: 1
- A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders2025RESTRICTEDTitle: A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disordersJournal Name: Statistics in Biopharmaceutical ResearchPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/19466315.2025.2458018Best OA location URL: https://arxiv.org/pdf/2410.19190Citation Count: 1
- Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s disease2025OPENTitle: Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1501319Best OA location URL: https://doi.org/10.3389/fnagi.2025.1501319Citation Count: 0